ARHGEF39 promotes tumor progression via activation of Rac1/P38 MAPK/ATF2 signaling and predicts poor prognosis in non-small cell lung cancer patients.

Zhou H, Cai L, Zhang X, Li A, Miao Y, Li Q, Qiu X, Wang E
Lab Invest. 2018 May;98(5):670-681. doi: 10.1038/s41374-018-0022-y. Epub 2018 Jan 30. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.